Elisa Caiola
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Erratum: Molecular determinants of response to PI3K/AKT/mTOR and KRAS pathways inhibitors in NSCLC cell lines.
Journal: American journal of cancer research
Published: February 12, 2026
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring.
Journal: Frontiers in oncology
Published: October 04, 2024
LKB1: Can We Target an Hidden Target? Focus on NSCLC.
Journal: Frontiers in oncology
Published: March 04, 2022
miR-17 Epigenetic Modulation of LKB1 Expression in Tumor Cells Uncovers a New Group of Patients With Poor-Prognosis NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 25, 2021
Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy.
Journal: ESMO open
Published: October 19, 2020
It's Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?
Journal: Cancers
Published: October 09, 2020
Molecular determinants of response to PI3K/akt/mTOR and KRAS pathways inhibitors in NSCLC cell lines.
Journal: American journal of cancer research
Published: September 25, 2020
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 30, 2020
Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy.
Journal: Journal of clinical medicine
Published: June 26, 2020
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation.
Journal: Cells
Published: February 17, 2020
Last Updated: 09/26/2026